Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Feb 15;97(4):910–914. doi: 10.1172/JCI118513

Autoantibodies to the extracellular domain of the calcium sensing receptor in patients with acquired hypoparathyroidism.

Y Li 1, Y H Song 1, N Rais 1, E Connor 1, D Schatz 1, A Muir 1, N Maclaren 1
PMCID: PMC507135  PMID: 8613543

Abstract

Acquired hypoparathyroidism (AH) has been considered to result from an autoimmune process but the self-antigens have not been identified. We studied 25 patients with AH, of which 17 had type I autoimmune polyglandular syndrome and 8 had AH associated with autoimmune hypothyroidism. Five of 25 (20%) AH sera reacted to a membrane-associated antigen of 120-140 kD in human parathyroid gland extracts using immunoblot analysis. This is the exact size of the calcium sensing receptor (Ca-SR). The AH sera were then tested by immunoblot using a membrane fraction of HEK-293 cells transfected with Ca-SR cDNA. Eight of 25 (32%) AH sera reacted to a 120-140-kD protein, which closely matched that recognized by the anti-Ca-SR IgG raised in rabbits. The Ca-SR cDNA was translated in vitro into two parts in order to identify the antigenic epitopes. By using this technique, 14 of 25 (56%) AH sera were positive to the extracellular domain of the Ca-SR, whereas none of the AH patients sera reacted to the intracellular domain. The reactivity of the positive sera was completely removed after pre-absorption with the Ca-SR containing membranes. Sera from 50 patients with various other autoimmune diseases as well as 22 normal controls were also tested, and none of them was positive. In conclusion, the Ca-SR has been identified as an autoantigen in AH.

Full Text

The Full Text of this article is available as a PDF (194.7 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aaltonen J., Björses P., Sandkuijl L., Perheentupa J., Peltonen L. An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21. Nat Genet. 1994 Sep;8(1):83–87. doi: 10.1038/ng0994-83. [DOI] [PubMed] [Google Scholar]
  2. Ahonen P., Koskimies S., Lokki M. L., Tiilikainen A., Perheentupa J. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab. 1988 Jun;66(6):1152–1157. doi: 10.1210/jcem-66-6-1152. [DOI] [PubMed] [Google Scholar]
  3. Ahonen P., Myllärniemi S., Sipilä I., Perheentupa J. Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients. N Engl J Med. 1990 Jun 28;322(26):1829–1836. doi: 10.1056/NEJM199006283222601. [DOI] [PubMed] [Google Scholar]
  4. Betterle C., Caretto A., Zeviani M., Pedini B., Salviati C. Demonstration and characterization of anti-human mitochondria autoantibodies in idiopathic hypoparathyroidism and in other conditions. Clin Exp Immunol. 1985 Nov;62(2):353–360. [PMC free article] [PubMed] [Google Scholar]
  5. Blizzard R. M., Chee D., Davis W. The incidence of parathyroid and other antibodies in the sera of patients with idiopathic hypoparathyroidism. Clin Exp Immunol. 1966 Apr;1(2):119–128. [PMC free article] [PubMed] [Google Scholar]
  6. Brandi M. L., Aurbach G. D., Fattorossi A., Quarto R., Marx S. J., Fitzpatrick L. A. Antibodies cytotoxic to bovine parathyroid cells in autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A. 1986 Nov;83(21):8366–8369. doi: 10.1073/pnas.83.21.8366. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Brown E. M., Gamba G., Riccardi D., Lombardi M., Butters R., Kifor O., Sun A., Hediger M. A., Lytton J., Hebert S. C. Cloning and characterization of an extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 1993 Dec 9;366(6455):575–580. doi: 10.1038/366575a0. [DOI] [PubMed] [Google Scholar]
  8. Desouki A., Eldefrawi A. T., Eldefrawi M. E. A new mechanism revealed for the action of antibodies on acetylcholine receptor function. Exp Neurol. 1981 Aug;73(2):440–450. doi: 10.1016/0014-4886(81)90278-8. [DOI] [PubMed] [Google Scholar]
  9. Fattorossi A., Aurbach G. D., Sakaguchi K., Cama A., Marx S. J., Streeten E. A., Fitzpatrick L. A., Brandi M. L. Anti-endothelial cell antibodies: detection and characterization in sera from patients with autoimmune hypoparathyroidism. Proc Natl Acad Sci U S A. 1988 Jun;85(11):4015–4019. doi: 10.1073/pnas.85.11.4015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fumagalli G., Engel A. G., Lindstrom J. Ultrastructural aspects of acetylcholine receptor turnover at the normal end-plate and in autoimmune myasthenia gravis. J Neuropathol Exp Neurol. 1982 Nov;41(6):567–579. doi: 10.1097/00005072-198211000-00001. [DOI] [PubMed] [Google Scholar]
  11. Gonzalez-Ros J. M., Ferragut J. A., Martinez-Carrion M. Binding of anti-acetylcholine receptor antibodies inhibits the acetylcholine receptor mediated cation flux. Biochem Biophys Res Commun. 1984 Apr 30;120(2):368–375. doi: 10.1016/0006-291x(84)91263-4. [DOI] [PubMed] [Google Scholar]
  12. Maclaren N. K., Riley W. J. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care. 1985 Sep-Oct;8 (Suppl 1):34–38. doi: 10.2337/diacare.8.1.s34. [DOI] [PubMed] [Google Scholar]
  13. Muir A., Maclaren N. K. Autoimmune diseases of the adrenal glands, parathyroid glands, gonads, and hypothalamic-pituitary axis. Endocrinol Metab Clin North Am. 1991 Sep;20(3):619–644. [PubMed] [Google Scholar]
  14. Neufeld M., Maclaren N. K., Blizzard R. M. Two types of autoimmune Addison's disease associated with different polyglandular autoimmune (PGA) syndromes. Medicine (Baltimore) 1981 Sep;60(5):355–362. doi: 10.1097/00005792-198109000-00003. [DOI] [PubMed] [Google Scholar]
  15. Neufeld M., Maclaren N., Blizzard R. Autoimmune polyglandular syndromes. Pediatr Ann. 1980 Apr;9(4):154–162. [PubMed] [Google Scholar]
  16. Posillico J. T., Wortsman J., Srikanta S., Eisenbarth G. S., Mallette L. E., Brown E. M. Parathyroid cell surface autoantibodies that inhibit parathyroid hormone secretion from dispersed human parathyroid cells. J Bone Miner Res. 1986 Oct;1(5):475–483. doi: 10.1002/jbmr.5650010512. [DOI] [PubMed] [Google Scholar]
  17. Song Y. H., Connor E., Li Y., Zorovich B., Balducci P., Maclaren N. The role of tyrosinase in autoimmune vitiligo. Lancet. 1994 Oct 15;344(8929):1049–1052. doi: 10.1016/s0140-6736(94)91709-4. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES